Associated Press
Stocks Fall on Poor Retail Sales, Oil
10.07.2004, 04:33 PM
Investors sent stocks sharply lower Friday as oil prices continued their climb higher and new questions about the safety of arthritis drugs pressured pharmaceutical stocks. The Dow Jones industrials, which include drug makers Pfizer Inc. and Merck & Co., lost more than 114 points.
Uninspiring September retail sales contributed to the market's malaise.
Investors were newly uneasy about drug stocks after a new scientific study showed that Pfizer's Celebrex could cause cardiovascular problems similar to those caused by Merck's Vioxx, which was pulled from the market last week after Merck found a heightened risk of heart attack and stroke. The news fed selling in the rest of the drug sector.
Investors also bid stocks lower as oil prices reached a record $53 per barrel in intraday trading, as production problems in Russia, Nigeria and the Gulf of Mexico combined to spark another wave of speculation. A barrel of crude oil settled at $52.67, up 65 cents, on the New York Mercantile Exchange.
"Oil continues to be the big story here, and it's going to be hard for the markets to break out of a range while this continues to be a problem," said Joseph Battipaglia, chief investment officer at Ryan Beck & Co. "It adds to the uncertainty in the market over earnings and the election."
More ...
http://www.forbes.com/infoimaging/feeds/ap/2004/10/07/ap1581804.htmlSpin this ya White House Squatting Frat Boy!